Rifamycin Market, Global Outlook and Forecast 2022-2028

August 2022 | 113 pages | ID: RBB94B568A04EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Rifamycin in Global, including the following market information:

Global Rifamycin Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Rifamycin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Rifamycin include Merck, Labcorp Drug Development, Mylan, Sandoz, Sanofi Pharmaceuticals, AdvaCare Pharma, EUROAPI, Lupin Ltd and Olon S.p.A, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rifamycin companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Rifamycin Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Rifamycin Market Segment Percentages, by Type, 2021 (%)

• Tablet
• Capsule

Global Rifamycin Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Rifamycin Market Segment Percentages, by Application, 2021 (%)

• Pharmacy
• Hospital
• Clinic
• Others

Global Rifamycin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Rifamycin Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Rifamycin revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Rifamycin revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• Labcorp Drug Development
• Mylan
• Sandoz
• Sanofi Pharmaceuticals
• AdvaCare Pharma
• EUROAPI
• Lupin Ltd
• Olon S.p.A
• CKD Bio Corporation
• Fermic
• Sichuan Long March Pharmaceutical Co. Ltd.
• Novartis Pharmaceuticals Corporation
• Hanways Chempharm Co., Limited
• Otto Brandes
• Arudavis Labs
• Zhengzhou Minzhong Pharmaceutical Co., Ltd
• Lannett
• Acme Pharmaceuticals
• Macleods Pharmaceuticals Ltd.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Rifamycin Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Rifamycin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RIFAMYCIN OVERALL MARKET SIZE

2.1 Global Rifamycin Market Size: 2021 VS 2028
2.2 Global Rifamycin Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Rifamycin Players in Global Market
3.2 Top Global Rifamycin Companies Ranked by Revenue
3.3 Global Rifamycin Revenue by Companies
3.4 Top 3 and Top 5 Rifamycin Companies in Global Market, by Revenue in 2021
3.5 Global Companies Rifamycin Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rifamycin Players in Global Market
  3.6.1 List of Global Tier 1 Rifamycin Companies
  3.6.2 List of Global Tier 2 and Tier 3 Rifamycin Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Rifamycin Market Size Markets, 2021 & 2028
  4.1.2 Tablet
  4.1.3 Capsule
4.2 By Type - Global Rifamycin Revenue & Forecasts
  4.2.1 By Type - Global Rifamycin Revenue, 2017-2022
  4.2.2 By Type - Global Rifamycin Revenue, 2023-2028
  4.2.3 By Type - Global Rifamycin Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Rifamycin Market Size, 2021 & 2028
  5.1.2 Pharmacy
  5.1.3 Hospital
  5.1.4 Clinic
  5.1.5 Others
5.2 By Application - Global Rifamycin Revenue & Forecasts
  5.2.1 By Application - Global Rifamycin Revenue, 2017-2022
  5.2.2 By Application - Global Rifamycin Revenue, 2023-2028
  5.2.3 By Application - Global Rifamycin Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Rifamycin Market Size, 2021 & 2028
6.2 By Region - Global Rifamycin Revenue & Forecasts
  6.2.1 By Region - Global Rifamycin Revenue, 2017-2022
  6.2.2 By Region - Global Rifamycin Revenue, 2023-2028
  6.2.3 By Region - Global Rifamycin Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Rifamycin Revenue, 2017-2028
  6.3.2 US Rifamycin Market Size, 2017-2028
  6.3.3 Canada Rifamycin Market Size, 2017-2028
  6.3.4 Mexico Rifamycin Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Rifamycin Revenue, 2017-2028
  6.4.2 Germany Rifamycin Market Size, 2017-2028
  6.4.3 France Rifamycin Market Size, 2017-2028
  6.4.4 U.K. Rifamycin Market Size, 2017-2028
  6.4.5 Italy Rifamycin Market Size, 2017-2028
  6.4.6 Russia Rifamycin Market Size, 2017-2028
  6.4.7 Nordic Countries Rifamycin Market Size, 2017-2028
  6.4.8 Benelux Rifamycin Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Rifamycin Revenue, 2017-2028
  6.5.2 China Rifamycin Market Size, 2017-2028
  6.5.3 Japan Rifamycin Market Size, 2017-2028
  6.5.4 South Korea Rifamycin Market Size, 2017-2028
  6.5.5 Southeast Asia Rifamycin Market Size, 2017-2028
  6.5.6 India Rifamycin Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Rifamycin Revenue, 2017-2028
  6.6.2 Brazil Rifamycin Market Size, 2017-2028
  6.6.3 Argentina Rifamycin Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Rifamycin Revenue, 2017-2028
  6.7.2 Turkey Rifamycin Market Size, 2017-2028
  6.7.3 Israel Rifamycin Market Size, 2017-2028
  6.7.4 Saudi Arabia Rifamycin Market Size, 2017-2028
  6.7.5 UAE Rifamycin Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck Rifamycin Major Product Offerings
  7.1.4 Merck Rifamycin Revenue in Global Market (2017-2022)
  7.1.5 Merck Key News
7.2 Labcorp Drug Development
  7.2.1 Labcorp Drug Development Corporate Summary
  7.2.2 Labcorp Drug Development Business Overview
  7.2.3 Labcorp Drug Development Rifamycin Major Product Offerings
  7.2.4 Labcorp Drug Development Rifamycin Revenue in Global Market (2017-2022)
  7.2.5 Labcorp Drug Development Key News
7.3 Mylan
  7.3.1 Mylan Corporate Summary
  7.3.2 Mylan Business Overview
  7.3.3 Mylan Rifamycin Major Product Offerings
  7.3.4 Mylan Rifamycin Revenue in Global Market (2017-2022)
  7.3.5 Mylan Key News
7.4 Sandoz
  7.4.1 Sandoz Corporate Summary
  7.4.2 Sandoz Business Overview
  7.4.3 Sandoz Rifamycin Major Product Offerings
  7.4.4 Sandoz Rifamycin Revenue in Global Market (2017-2022)
  7.4.5 Sandoz Key News
7.5 Sanofi Pharmaceuticals
  7.5.1 Sanofi Pharmaceuticals Corporate Summary
  7.5.2 Sanofi Pharmaceuticals Business Overview
  7.5.3 Sanofi Pharmaceuticals Rifamycin Major Product Offerings
  7.5.4 Sanofi Pharmaceuticals Rifamycin Revenue in Global Market (2017-2022)
  7.5.5 Sanofi Pharmaceuticals Key News
7.6 AdvaCare Pharma
  7.6.1 AdvaCare Pharma Corporate Summary
  7.6.2 AdvaCare Pharma Business Overview
  7.6.3 AdvaCare Pharma Rifamycin Major Product Offerings
  7.6.4 AdvaCare Pharma Rifamycin Revenue in Global Market (2017-2022)
  7.6.5 AdvaCare Pharma Key News
7.7 EUROAPI
  7.7.1 EUROAPI Corporate Summary
  7.7.2 EUROAPI Business Overview
  7.7.3 EUROAPI Rifamycin Major Product Offerings
  7.7.4 EUROAPI Rifamycin Revenue in Global Market (2017-2022)
  7.7.5 EUROAPI Key News
7.8 Lupin Ltd
  7.8.1 Lupin Ltd Corporate Summary
  7.8.2 Lupin Ltd Business Overview
  7.8.3 Lupin Ltd Rifamycin Major Product Offerings
  7.8.4 Lupin Ltd Rifamycin Revenue in Global Market (2017-2022)
  7.8.5 Lupin Ltd Key News
7.9 Olon S.p.A
  7.9.1 Olon S.p.A Corporate Summary
  7.9.2 Olon S.p.A Business Overview
  7.9.3 Olon S.p.A Rifamycin Major Product Offerings
  7.9.4 Olon S.p.A Rifamycin Revenue in Global Market (2017-2022)
  7.9.5 Olon S.p.A Key News
7.10 CKD Bio Corporation
  7.10.1 CKD Bio Corporation Corporate Summary
  7.10.2 CKD Bio Corporation Business Overview
  7.10.3 CKD Bio Corporation Rifamycin Major Product Offerings
  7.10.4 CKD Bio Corporation Rifamycin Revenue in Global Market (2017-2022)
  7.10.5 CKD Bio Corporation Key News
7.11 Fermic
  7.11.1 Fermic Corporate Summary
  7.11.2 Fermic Business Overview
  7.11.3 Fermic Rifamycin Major Product Offerings
  7.11.4 Fermic Rifamycin Revenue in Global Market (2017-2022)
  7.11.5 Fermic Key News
7.12 Sichuan Long March Pharmaceutical Co. Ltd.
  7.12.1 Sichuan Long March Pharmaceutical Co. Ltd. Corporate Summary
  7.12.2 Sichuan Long March Pharmaceutical Co. Ltd. Business Overview
  7.12.3 Sichuan Long March Pharmaceutical Co. Ltd. Rifamycin Major Product Offerings
  7.12.4 Sichuan Long March Pharmaceutical Co. Ltd. Rifamycin Revenue in Global Market (2017-2022)
  7.12.5 Sichuan Long March Pharmaceutical Co. Ltd. Key News
7.13 Novartis Pharmaceuticals Corporation
  7.13.1 Novartis Pharmaceuticals Corporation Corporate Summary
  7.13.2 Novartis Pharmaceuticals Corporation Business Overview
  7.13.3 Novartis Pharmaceuticals Corporation Rifamycin Major Product Offerings
  7.13.4 Novartis Pharmaceuticals Corporation Rifamycin Revenue in Global Market (2017-2022)
  7.13.5 Novartis Pharmaceuticals Corporation Key News
7.14 Hanways Chempharm Co., Limited
  7.14.1 Hanways Chempharm Co., Limited Corporate Summary
  7.14.2 Hanways Chempharm Co., Limited Business Overview
  7.14.3 Hanways Chempharm Co., Limited Rifamycin Major Product Offerings
  7.14.4 Hanways Chempharm Co., Limited Rifamycin Revenue in Global Market (2017-2022)
  7.14.5 Hanways Chempharm Co., Limited Key News
7.15 Otto Brandes
  7.15.1 Otto Brandes Corporate Summary
  7.15.2 Otto Brandes Business Overview
  7.15.3 Otto Brandes Rifamycin Major Product Offerings
  7.15.4 Otto Brandes Rifamycin Revenue in Global Market (2017-2022)
  7.15.5 Otto Brandes Key News
7.16 Arudavis Labs
  7.16.1 Arudavis Labs Corporate Summary
  7.16.2 Arudavis Labs Business Overview
  7.16.3 Arudavis Labs Rifamycin Major Product Offerings
  7.16.4 Arudavis Labs Rifamycin Revenue in Global Market (2017-2022)
  7.16.5 Arudavis Labs Key News
7.17 Zhengzhou Minzhong Pharmaceutical Co., Ltd
  7.17.1 Zhengzhou Minzhong Pharmaceutical Co., Ltd Corporate Summary
  7.17.2 Zhengzhou Minzhong Pharmaceutical Co., Ltd Business Overview
  7.17.3 Zhengzhou Minzhong Pharmaceutical Co., Ltd Rifamycin Major Product Offerings
  7.17.4 Zhengzhou Minzhong Pharmaceutical Co., Ltd Rifamycin Revenue in Global Market (2017-2022)
  7.17.5 Zhengzhou Minzhong Pharmaceutical Co., Ltd Key News
7.18 Lannett
  7.18.1 Lannett Corporate Summary
  7.18.2 Lannett Business Overview
  7.18.3 Lannett Rifamycin Major Product Offerings
  7.18.4 Lannett Rifamycin Revenue in Global Market (2017-2022)
  7.18.5 Lannett Key News
7.19 Acme Pharmaceuticals
  7.19.1 Acme Pharmaceuticals Corporate Summary
  7.19.2 Acme Pharmaceuticals Business Overview
  7.19.3 Acme Pharmaceuticals Rifamycin Major Product Offerings
  7.19.4 Acme Pharmaceuticals Rifamycin Revenue in Global Market (2017-2022)
  7.19.5 Acme Pharmaceuticals Key News
7.20 Macleods Pharmaceuticals Ltd.
  7.20.1 Macleods Pharmaceuticals Ltd. Corporate Summary
  7.20.2 Macleods Pharmaceuticals Ltd. Business Overview
  7.20.3 Macleods Pharmaceuticals Ltd. Rifamycin Major Product Offerings
  7.20.4 Macleods Pharmaceuticals Ltd. Rifamycin Revenue in Global Market (2017-2022)
  7.20.5 Macleods Pharmaceuticals Ltd. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Rifamycin Market Opportunities & Trends in Global Market
Table 2. Rifamycin Market Drivers in Global Market
Table 3. Rifamycin Market Restraints in Global Market
Table 4. Key Players of Rifamycin in Global Market
Table 5. Top Rifamycin Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Rifamycin Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Rifamycin Revenue Share by Companies, 2017-2022
Table 8. Global Companies Rifamycin Product Type
Table 9. List of Global Tier 1 Rifamycin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rifamycin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Rifamycin Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Rifamycin Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Rifamycin Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Rifamycin Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Rifamycin Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Rifamycin Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Rifamycin Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Rifamycin Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Rifamycin Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Rifamycin Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Rifamycin Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Rifamycin Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Rifamycin Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Rifamycin Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Rifamycin Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Rifamycin Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Rifamycin Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Rifamycin Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Rifamycin Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck Rifamycin Product Offerings
Table 32. Merck Rifamycin Revenue (US$, Mn), (2017-2022)
Table 33. Labcorp Drug Development Corporate Summary
Table 34. Labcorp Drug Development Rifamycin Product Offerings
Table 35. Labcorp Drug Development Rifamycin Revenue (US$, Mn), (2017-2022)
Table 36. Mylan Corporate Summary
Table 37. Mylan Rifamycin Product Offerings
Table 38. Mylan Rifamycin Revenue (US$, Mn), (2017-2022)
Table 39. Sandoz Corporate Summary
Table 40. Sandoz Rifamycin Product Offerings
Table 41. Sandoz Rifamycin Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi Pharmaceuticals Corporate Summary
Table 43. Sanofi Pharmaceuticals Rifamycin Product Offerings
Table 44. Sanofi Pharmaceuticals Rifamycin Revenue (US$, Mn), (2017-2022)
Table 45. AdvaCare Pharma Corporate Summary
Table 46. AdvaCare Pharma Rifamycin Product Offerings
Table 47. AdvaCare Pharma Rifamycin Revenue (US$, Mn), (2017-2022)
Table 48. EUROAPI Corporate Summary
Table 49. EUROAPI Rifamycin Product Offerings
Table 50. EUROAPI Rifamycin Revenue (US$, Mn), (2017-2022)
Table 51. Lupin Ltd Corporate Summary
Table 52. Lupin Ltd Rifamycin Product Offerings
Table 53. Lupin Ltd Rifamycin Revenue (US$, Mn), (2017-2022)
Table 54. Olon S.p.A Corporate Summary
Table 55. Olon S.p.A Rifamycin Product Offerings
Table 56. Olon S.p.A Rifamycin Revenue (US$, Mn), (2017-2022)
Table 57. CKD Bio Corporation Corporate Summary
Table 58. CKD Bio Corporation Rifamycin Product Offerings
Table 59. CKD Bio Corporation Rifamycin Revenue (US$, Mn), (2017-2022)
Table 60. Fermic Corporate Summary
Table 61. Fermic Rifamycin Product Offerings
Table 62. Fermic Rifamycin Revenue (US$, Mn), (2017-2022)
Table 63. Sichuan Long March Pharmaceutical Co. Ltd. Corporate Summary
Table 64. Sichuan Long March Pharmaceutical Co. Ltd. Rifamycin Product Offerings
Table 65. Sichuan Long March Pharmaceutical Co. Ltd. Rifamycin Revenue (US$, Mn), (2017-2022)
Table 66. Novartis Pharmaceuticals Corporation Corporate Summary
Table 67. Novartis Pharmaceuticals Corporation Rifamycin Product Offerings
Table 68. Novartis Pharmaceuticals Corporation Rifamycin Revenue (US$, Mn), (2017-2022)
Table 69. Hanways Chempharm Co., Limited Corporate Summary
Table 70. Hanways Chempharm Co., Limited Rifamycin Product Offerings
Table 71. Hanways Chempharm Co., Limited Rifamycin Revenue (US$, Mn), (2017-2022)
Table 72. Otto Brandes Corporate Summary
Table 73. Otto Brandes Rifamycin Product Offerings
Table 74. Otto Brandes Rifamycin Revenue (US$, Mn), (2017-2022)
Table 75. Arudavis Labs Corporate Summary
Table 76. Arudavis Labs Rifamycin Product Offerings
Table 77. Arudavis Labs Rifamycin Revenue (US$, Mn), (2017-2022)
Table 78. Zhengzhou Minzhong Pharmaceutical Co., Ltd Corporate Summary
Table 79. Zhengzhou Minzhong Pharmaceutical Co., Ltd Rifamycin Product Offerings
Table 80. Zhengzhou Minzhong Pharmaceutical Co., Ltd Rifamycin Revenue (US$, Mn), (2017-2022)
Table 81. Lannett Corporate Summary
Table 82. Lannett Rifamycin Product Offerings
Table 83. Lannett Rifamycin Revenue (US$, Mn), (2017-2022)
Table 84. Acme Pharmaceuticals Corporate Summary
Table 85. Acme Pharmaceuticals Rifamycin Product Offerings
Table 86. Acme Pharmaceuticals Rifamycin Revenue (US$, Mn), (2017-2022)
Table 87. Macleods Pharmaceuticals Ltd. Corporate Summary
Table 88. Macleods Pharmaceuticals Ltd. Rifamycin Product Offerings
Table 89. Macleods Pharmaceuticals Ltd. Rifamycin Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Rifamycin Segment by Type in 2021
Figure 2. Rifamycin Segment by Application in 2021
Figure 3. Global Rifamycin Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Rifamycin Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Rifamycin Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rifamycin Revenue in 2021
Figure 8. By Type - Global Rifamycin Revenue Market Share, 2017-2028
Figure 9. By Application - Global Rifamycin Revenue Market Share, 2017-2028
Figure 10. By Region - Global Rifamycin Revenue Market Share, 2017-2028
Figure 11. By Country - North America Rifamycin Revenue Market Share, 2017-2028
Figure 12. US Rifamycin Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Rifamycin Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Rifamycin Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Rifamycin Revenue Market Share, 2017-2028
Figure 16. Germany Rifamycin Revenue, (US$, Mn), 2017-2028
Figure 17. France Rifamycin Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Rifamycin Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Rifamycin Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Rifamycin Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Rifamycin Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Rifamycin Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Rifamycin Revenue Market Share, 2017-2028
Figure 24. China Rifamycin Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Rifamycin Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Rifamycin Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Rifamycin Revenue, (US$, Mn), 2017-2028
Figure 28. India Rifamycin Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Rifamycin Revenue Market Share, 2017-2028
Figure 30. Brazil Rifamycin Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Rifamycin Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Rifamycin Revenue Market Share, 2017-2028
Figure 33. Turkey Rifamycin Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Rifamycin Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Rifamycin Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Rifamycin Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Rifamycin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Labcorp Drug Development Rifamycin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Mylan Rifamycin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sandoz Rifamycin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi Pharmaceuticals Rifamycin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AdvaCare Pharma Rifamycin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. EUROAPI Rifamycin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Lupin Ltd Rifamycin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Olon S.p.A Rifamycin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. CKD Bio Corporation Rifamycin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Fermic Rifamycin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Sichuan Long March Pharmaceutical Co. Ltd. Rifamycin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Novartis Pharmaceuticals Corporation Rifamycin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Hanways Chempharm Co., Limited Rifamycin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Otto Brandes Rifamycin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Arudavis Labs Rifamycin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Zhengzhou Minzhong Pharmaceutical Co., Ltd Rifamycin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Lannett Rifamycin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Acme Pharmaceuticals Rifamycin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Macleods Pharmaceuticals Ltd. Rifamycin Revenue Year Over Year Growth (US$, Mn) & (2017-2022)